Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CAMP4 Therapeutics Corporation - Common Stock (NQ:CAMP)

1.390 -0.060 (-4.14%)
Streaming Delayed Price Updated: 12:05 PM EDT, Jul 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 43,590
Open 1.450
Bid (Size) 1.380 (1)
Ask (Size) 1.400 (1)
Prev. Close 1.450
Today's Range 1.340 - 1.460
52wk Range 1.305 - 12.30
Shares Outstanding 20,161,073
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Sequans Appoints Jason W. Cohenour to Board of Directors
Paris, France--(Newsfile Corp. - June 30, 2025) - Sequans Communications S.A. (NYSE: SQNS), a leading innovator in cellular IoT semiconductor... 
Via Newsfile
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga

Performance

YTD
-71.8%
-71.8%
1 Month
-30.5%
-30.5%
3 Month
-65.3%
-65.3%
6 Month
-74.3%
-74.3%
1 Year
-87.0%
-87.0%

More News

Read More
This Sandisk Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Via Benzinga
CAMP4 Presents Translational Data from SYNGAP1-Related Disorders Program Showcasing Increased Protein in Non-Human Primates and Reviews Preclinical and Detailed Single Ascending Dose Safety Data from Urea Cycle Disorders Program at the 28th American
From CAMP4 Therapeutics
Via GlobeNewswire
CAMP4 Reports First Quarter 2025 Financial Results and Corporate Highlights
From CAMP4 Therapeutics
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why ThredUp Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
CAMP4 to Present New Preclinical Data from its Urea Cycle Disorders and SYNGAP1-Related Disorders Programs at the 28th American Society of Gene and Cell Therapy Annual Meeting
From CAMP4 Therapeutics
Via GlobeNewswire
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q2
Via Benzinga
CAMP4 Reports Full Year 2024 Financial Results and Provides Corporate Update
From CAMP4 Therapeutics
Via GlobeNewswire
CAMP4 Appoints Multiple Industry Veterans to its Board of Directors
From CAMP4 Therapeutics
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
CAMP4 to Participate in Upcoming Investor Conferences
From CAMP4 Therapeutics
Via GlobeNewswire
CAMP4 to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From CAMP4 Therapeutics
Via GlobeNewswire
CAMP4 Provides Corporate Updates and Highlights Key Upcoming Milestones
From CAMP4 Therapeutics
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
CAMP4 Appoints John Maraganore and Rachel Meyers as Strategic Advisors
From CAMP4 Therapeutics
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why DocuSign Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Via Benzinga
CAMP4 to Participate in the Piper Sandler 36th Annual Healthcare Conference
From CAMP4 Therapeutics
Via GlobeNewswire
CAMP4 Reports Third Quarter 2024 Financial Results
From CAMP4 Therapeutics
Via GlobeNewswire
CAMP4 Analyst Highlights Rare Disease Platform Potential
Via Benzinga
Topics Initial Public Offering
Another Trio Of Biotech IPOs Made Friday Debut
Via Talk Markets
CAMP4 Announces Pricing of Initial Public Offering
From CAMP4 Therapeutics
Via GlobeNewswire

Frequently Asked Questions

Is CAMP4 Therapeutics Corporation - Common Stock publicly traded?
Yes, CAMP4 Therapeutics Corporation - Common Stock is publicly traded.
What exchange does CAMP4 Therapeutics Corporation - Common Stock trade on?
CAMP4 Therapeutics Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for CAMP4 Therapeutics Corporation - Common Stock?
The ticker symbol for CAMP4 Therapeutics Corporation - Common Stock is CAMP on the Nasdaq Stock Market
What is the current price of CAMP4 Therapeutics Corporation - Common Stock?
The current price of CAMP4 Therapeutics Corporation - Common Stock is 1.390
When was CAMP4 Therapeutics Corporation - Common Stock last traded?
The last trade of CAMP4 Therapeutics Corporation - Common Stock was at 07/01/25 12:05 PM ET
What is the market capitalization of CAMP4 Therapeutics Corporation - Common Stock?
The market capitalization of CAMP4 Therapeutics Corporation - Common Stock is 28.02M
How many shares of CAMP4 Therapeutics Corporation - Common Stock are outstanding?
CAMP4 Therapeutics Corporation - Common Stock has 28M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.